3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Recurrence
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Hematologic Diseases
1
HER2 Positive Breast Carcinoma
1
Dendritic Cell Sarcoma, Interdigitating
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma of Lung
1
Interventions
Cyclophosphamide
46
fludarabine phosphate
24
Busulfan
22
Peripheral Blood Stem Cell Transplantation
20
Radiotherapy
19
Filgrastim
19
Mycophenolic Acid
18
Antilymphocyte Serum
18
Cyclosporine
17
Whole-Body Irradiation
16
Rituximab
16
Etoposide
16
Methotrexate
15
Melphalan
15
Methylprednisolone
14
Tacrolimus
12
Cytarabine
12
Vincristine
10
Prednisone
10
Doxorubicin
10
Cord Blood Stem Cell Transplantation
10
Thiotepa
6
Granulocyte Colony-Stimulating Factor
6
Leucovorin
5
sargramostim
4
fludarabine
4
Daunorubicin
4
glofitamab
3
Sirolimus
3
Methylprednisolone Hemisuccinate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Dendritic Cell Sarcoma, Interdigitating
×
Geriatric Assessment
×
Clear all
NCT04113226
2023-02-08
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Unknown
114 enrolled